Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Koa Accel CEO Francis Duhay tells Medtech Insight what his company looks for when choosing medtech ideas to support and how his experience as a physician and inventor informs his investment strategy.
Koa Accel CEO Francis Duhay outlines his company’s plans to take some of the risk out of investing in medical device start-ups by supporting inventors with functional expertise. The Irvine, CA-based medical device accelerator is focused on start-ups that will either “fail fast” or earn a 510(k) clearance within 18 months.
Exec Chat: XMed2019: How IBM Watson Health's CTO Uses Blockchain To Eliminate 'Friction Points' In Health Care
Ted Tanner, the new chief technology officer and chief architect of IBM Watson Health, recently sat down with Medtech Insight to discuss his plans for the company. In 2020, IBM will start testing the first use cases of its blockchain-based data information exchange network, a partnership with several health-care organizations, aimed at reducing administrative errors and costs. Tanner refers to blockchain as an "enablement platform" that augments computing power.
Exec Chat: XMed 2019: Intuitive Foundation's President Catherine Mohr's Team Jackets Read 'Plan For 100 Years'
At this week's Exponential Medicine conference, Medtech Insight sat down with the Intuitive Foundation's president, Catherine Mohr, to learn about her ambitions for the foundation and continued innovation at Intuitive Surgical.
With the opening of a new UK & Ireland headquarters last month, Intuitive Surgical is aiming to strengthen its grip on the the market as it faces increasing competition in the robotic surgery space. CEO Gary Guthart sat down with Medtech Insight at its new Oxfordshire, UK HQ to discuss expansion and innovation plans.
ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.